9:22 PM
Apr 06, 2017
 |  BC Week In Review  |  Company News  |  Deals

Calypso, EA Pharma deal

Calypso granted EA Pharma exclusive, worldwide rights to develop and commercialize preclinical candidate CALY-001. The companies will...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD